In the last few years a number of important studies relating to the investigation and management of ovarian cancer have firmly established a pivotal role in management for CT. CT provides accurate staging information, identifying key sites of disease which influence the success of cytoreductive surgery. CT facilitates histological diagnosis from needle core biopsy when surgery is considered inappropriate. These studies have provided a strong evidence base for current practice but we are left with some uncertainties.

Author

John A Spencer

Contact Details

Corresponding address:
Leeds Cancer Centre,
St James's University Hospital,
Leeds,
UK

Reference

ICIS Cancer Imaging volume 4
DOI: 10.1102/1470-7330.2003.0030

Date Posted

2 October 2003

Print PDF

Size

955.08 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	3 seconds
ADSL 512Kb/s (Broadband):	14 seconds
64 Kb/s (ISDN):	1 minute 59 seconds
33.3 Kb/s (Typical Modem):	3 minutes 49 seconds

Screen PDF

Size

219.47 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	1 second
ADSL 512Kb/s (Broadband):	3 seconds
64 Kb/s (ISDN):	27 seconds
33.3 Kb/s (Typical Modem):	52 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 61053, London, SE16 7YZ. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.